Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901565588> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2901565588 endingPage "99" @default.
- W2901565588 startingPage "98" @default.
- W2901565588 abstract "Chronic myeloid leukaemia (CML) is a myeloproliferative neoplasm that originates in an abnormal pluripotent bone marrow stem cell, usually presenting with leukocytosis with increased number of granulocytes (neutrophils, eosinophils and basophils) and their progenitors. CML is consistently associated with the reciprocal translocation of breakpoint cluster region protein (BCR) gene on chromosome 9 to Abelson murine leukaemia viral oncogene homolog 1 (ABL) gene on chromosome 22, resulting in a BCR-ABL fusion gene, which encodes an unregulated tyrosine kinase that allows the cells to proliferate without being regulated by cytokines.1Rowley J.D. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.Nature. 1973; 243: 290-293Crossref PubMed Scopus (3369) Google Scholar CML can rarely present as isolated thrombocytosis. Historically, atypical presentations of CML with marked thrombocytosis unaccompanied by significantly elevated granulocytes are usually associated with blast crisis or lymphoblastic transformation.2Peterson L.C. Bloomfield C.D. Brunning R.D. Blast crisis as an initial or terminal manifestation of chronic myeloid leukemia. A study of 28 patients.Am J Med. 1976; 60: 209-220Abstract Full Text PDF PubMed Scopus (104) Google Scholar, 3Anastasi J. Feng J. Dickstein J.I. et al.Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.Leukemia. 1996; 10: 795-802PubMed Google Scholar Since 2000, few case reports have described patients who presented initially with thrombocytosis without leukocytosis.4Rice L. Popat U. Every case of essential thrombocythemia should be tested for the Philadelphia chromosome.Am J Hematol. 2005; 78: 71-73Crossref PubMed Scopus (26) Google Scholar, 5Cesar J.M. Cabello P. Ferro T. et al.Emergence of chronic myelogenous leukemia in a patient with primary thrombocythemia and absence of BCR/ABL rearrangement.Cancer Genet Cytogenet. 2006; 167: 74-77Abstract Full Text Full Text PDF PubMed Scopus (9) Google Scholar, 6Weng W.H. Shih L.Y. Occurrence of BCR-ABL1-positive chronic myeloid leukemia following essential thrombocythemia.Acta Haematol. 2011; 126: 220-223Crossref PubMed Scopus (4) Google Scholar In two of these case reports, the cytogenetic studies were initially negative for the fusion gene in one case5Cesar J.M. Cabello P. Ferro T. et al.Emergence of chronic myelogenous leukemia in a patient with primary thrombocythemia and absence of BCR/ABL rearrangement.Cancer Genet Cytogenet. 2006; 167: 74-77Abstract Full Text Full Text PDF PubMed Scopus (9) Google Scholar while the molecular studies for BCR-ABL transcript were initially negative in the other.6Weng W.H. Shih L.Y. Occurrence of BCR-ABL1-positive chronic myeloid leukemia following essential thrombocythemia.Acta Haematol. 2011; 126: 220-223Crossref PubMed Scopus (4) Google Scholar At the molecular level, co-expression of p190 and p210 is associated with high platelet counts, marked splenomegaly and additional chromosomal abnormalities.7Arana-Trejo R.M. Ruíz Sánchez E. Ignacio-Ibarra G. et al.BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML).Clin Lab Haematol. 2002; 24: 145-150Crossref PubMed Scopus (40) Google Scholar The μ-BCR breakpoint associated with p230 BCR-ABL protein can also present with thrombocytosis.8Melo J.V. BCR-ABL gene variants.Baillieres Clin Haematol. 1997; 10: 203-222Abstract Full Text PDF PubMed Scopus (122) Google Scholar We undertook a retrospective review of 345 cases diagnosed in Western Australia from 2005 to 2016, with cytogenetic and molecular data available. Of these, we found 130 cases (38%) presented with thrombocytosis with a platelet count >450 × 109/L, accompanied with elevated white cell count >11 × 109/L. Only three cases (0.9%) presented with thrombocytosis and normal white cell counts (Table 1). All cases had abnormal blood films: left shift, red cell and platelet anisocytosis, and presence of occasional blasts are features described in the blood film morphology review. However, basophilia, typical of CML, was not observed.Table 1Characteristics of CML cases presenting with isolated thrombocytosisAge(years)GenderHb(g/L)WCC(×109/L)Plt(×109/L)MorphologyBreak-pointAdditional cytogenetic abnormalities66M15010539Left shiftB2A2Nil35F1075637Large platelet; occasional blasts seenB2A2Variant translocation80M1046499Myelocytes and rare dysplastic myeloid precursors; occasional blasts seenB3A2-YHb, haemoglobin; WCC, white cell count; Plt, platelets. Open table in a new tab Hb, haemoglobin; WCC, white cell count; Plt, platelets. At the genetic level, all three cases had major breakpoints, and no major route abnormalities were observed on conventional karyotype. In all three cases, we were able to detect the Ph chromosome by conventional fluorescence in situ hybridisation (FISH) either on the bone marrow or peripheral blood specimens. Thrombocytosis resolved in all three cases when BCR-ABL transcript levels declined with the commencement of tyrosine kinase inhibitors. While CML should be considered in the majority of unexplained leukocytosis with accompanying thrombocytosis, CML presenting with isolated thrombocytosis is rare. The approach recommended by some authors of screening all patients with unexplained persistent thrombocytosis9Passamonti F. Maffioli M. Update from the latest WHO classification of MPNs: a user's manual.Hematol Am Soc Hematol Educ Program. 2016; 2016: 534-542Crossref PubMed Scopus (35) Google Scholar may not be economically justifiable, given the cost of molecular or FISH testing. Rather, our data support the approach of reserving CML screening for cases where other myeloproliferative neoplams have been excluded, unless leukocytosis or atypical morphology is noted on the blood film. We recommend bone marrow examination with cytogenetic analysis to further investigate unexplained isolated thrombocytosis that is negative for JAK2, CALR and MPL mutations, in order to exclude CML and other rare causes such as 5q-syndrome. This approach will avoid missing atypical presentation of CML in the current era where targeted therapy significantly reduces transformation risks and improves survival. This approach is also in line with the British recommended diagnostic approach of unexplained thrombocytosis.10Harrison C.N. Butt N. Campbell P. et al.Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.Br J Haematol. 2014; 167: 421-423Crossref PubMed Scopus (36) Google Scholar The authors state that there are no conflicts of interest to disclose." @default.
- W2901565588 created "2018-11-29" @default.
- W2901565588 creator A5031940085 @default.
- W2901565588 creator A5039549733 @default.
- W2901565588 creator A5070176523 @default.
- W2901565588 date "2019-01-01" @default.
- W2901565588 modified "2023-09-26" @default.
- W2901565588 title "Approximately 1% of chronic myeloid leukaemia cases present with isolated thrombocytosis and express common major breakpoints: a finding from a laboratory audit" @default.
- W2901565588 cites W1964395467 @default.
- W2901565588 cites W1970329652 @default.
- W2901565588 cites W1986324312 @default.
- W2901565588 cites W1998593414 @default.
- W2901565588 cites W2014088028 @default.
- W2901565588 cites W2083971818 @default.
- W2901565588 cites W2120336245 @default.
- W2901565588 cites W2163764464 @default.
- W2901565588 cites W2559137855 @default.
- W2901565588 doi "https://doi.org/10.1016/j.pathol.2018.09.059" @default.
- W2901565588 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30477881" @default.
- W2901565588 hasPublicationYear "2019" @default.
- W2901565588 type Work @default.
- W2901565588 sameAs 2901565588 @default.
- W2901565588 citedByCount "2" @default.
- W2901565588 countsByYear W29015655882021 @default.
- W2901565588 countsByYear W29015655882023 @default.
- W2901565588 crossrefType "journal-article" @default.
- W2901565588 hasAuthorship W2901565588A5031940085 @default.
- W2901565588 hasAuthorship W2901565588A5039549733 @default.
- W2901565588 hasAuthorship W2901565588A5070176523 @default.
- W2901565588 hasConcept C104317684 @default.
- W2901565588 hasConcept C125418893 @default.
- W2901565588 hasConcept C126322002 @default.
- W2901565588 hasConcept C138626823 @default.
- W2901565588 hasConcept C142724271 @default.
- W2901565588 hasConcept C170493617 @default.
- W2901565588 hasConcept C203014093 @default.
- W2901565588 hasConcept C2776960273 @default.
- W2901565588 hasConcept C2778461978 @default.
- W2901565588 hasConcept C2778904597 @default.
- W2901565588 hasConcept C2778923028 @default.
- W2901565588 hasConcept C2779282312 @default.
- W2901565588 hasConcept C2779788118 @default.
- W2901565588 hasConcept C2780007613 @default.
- W2901565588 hasConcept C2780076729 @default.
- W2901565588 hasConcept C2781107747 @default.
- W2901565588 hasConcept C42362537 @default.
- W2901565588 hasConcept C43907098 @default.
- W2901565588 hasConcept C502942594 @default.
- W2901565588 hasConcept C54355233 @default.
- W2901565588 hasConcept C71924100 @default.
- W2901565588 hasConcept C86803240 @default.
- W2901565588 hasConcept C89560881 @default.
- W2901565588 hasConceptScore W2901565588C104317684 @default.
- W2901565588 hasConceptScore W2901565588C125418893 @default.
- W2901565588 hasConceptScore W2901565588C126322002 @default.
- W2901565588 hasConceptScore W2901565588C138626823 @default.
- W2901565588 hasConceptScore W2901565588C142724271 @default.
- W2901565588 hasConceptScore W2901565588C170493617 @default.
- W2901565588 hasConceptScore W2901565588C203014093 @default.
- W2901565588 hasConceptScore W2901565588C2776960273 @default.
- W2901565588 hasConceptScore W2901565588C2778461978 @default.
- W2901565588 hasConceptScore W2901565588C2778904597 @default.
- W2901565588 hasConceptScore W2901565588C2778923028 @default.
- W2901565588 hasConceptScore W2901565588C2779282312 @default.
- W2901565588 hasConceptScore W2901565588C2779788118 @default.
- W2901565588 hasConceptScore W2901565588C2780007613 @default.
- W2901565588 hasConceptScore W2901565588C2780076729 @default.
- W2901565588 hasConceptScore W2901565588C2781107747 @default.
- W2901565588 hasConceptScore W2901565588C42362537 @default.
- W2901565588 hasConceptScore W2901565588C43907098 @default.
- W2901565588 hasConceptScore W2901565588C502942594 @default.
- W2901565588 hasConceptScore W2901565588C54355233 @default.
- W2901565588 hasConceptScore W2901565588C71924100 @default.
- W2901565588 hasConceptScore W2901565588C86803240 @default.
- W2901565588 hasConceptScore W2901565588C89560881 @default.
- W2901565588 hasIssue "1" @default.
- W2901565588 hasLocation W29015655881 @default.
- W2901565588 hasLocation W29015655882 @default.
- W2901565588 hasOpenAccess W2901565588 @default.
- W2901565588 hasPrimaryLocation W29015655881 @default.
- W2901565588 hasRelatedWork W194591472 @default.
- W2901565588 hasRelatedWork W1956133770 @default.
- W2901565588 hasRelatedWork W1993703063 @default.
- W2901565588 hasRelatedWork W2030358741 @default.
- W2901565588 hasRelatedWork W2097082948 @default.
- W2901565588 hasRelatedWork W2240163084 @default.
- W2901565588 hasRelatedWork W2278825026 @default.
- W2901565588 hasRelatedWork W2336944454 @default.
- W2901565588 hasRelatedWork W2901565588 @default.
- W2901565588 hasRelatedWork W4296666343 @default.
- W2901565588 hasVolume "51" @default.
- W2901565588 isParatext "false" @default.
- W2901565588 isRetracted "false" @default.
- W2901565588 magId "2901565588" @default.
- W2901565588 workType "article" @default.